Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov 20;398(10314):1874.
doi: 10.1016/S0140-6736(21)02286-8.

CoronaVac efficacy data from Turkey - Authors' reply

Mine Durusu Tanriover  1 , Hamdi Levent Doğanay  2 , Serhat Unal  3 , Murat Akova  4
Affiliations
Comment

CoronaVac efficacy data from Turkey - Authors' reply

Mine Durusu Tanriover et al. Lancet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

  • CoronaVac efficacy data from Turkey.
    McMenamin ME, Cowling BJ. McMenamin ME, et al. Lancet. 2021 Nov 20;398(10314):1873-1874. doi: 10.1016/S0140-6736(21)02288-1. Lancet. 2021. PMID: 34801104 Free PMC article. No abstract available.

References

    1. Tanriover MD, Doğanay HL, Akova M, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398:213–222. - PMC - PubMed
    1. Palacios R, Batista AP, Albuquerque CSN, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV Study. SSRN. 2021 doi: 10.2139/ssrn.3822780. published online April 11. (preprint). - DOI
    1. Fadlyana E, Rusmil K, Tarigan R, et al. Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia. Vaccine. 2021;39:6520–6528. - PMC - PubMed
    1. Jara A, Undurraga EA, González C, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385:875–884. - PMC - PubMed